Quality & compliance
Quality, documentation and manufacturing scale
Buyers rarely fail a pen program on price. They fail it on documents. This page states what we can be held to: production scale, the inspection gates every batch passes, and exactly which documents exist for your due diligence file.
What we can be measured on
Five figures that appear consistently across this site, our guide and our AI-facing index.
- Annual capacity
- 80 million units / year
- Plant area
- 10,000 m2
- Team
- 500 people
- Export markets
- 60 countries
- Patents
- 50+ patents
Disposable and reusable pen platforms on the same production floor.
Mould workshop, injection molding, assembly and inspection under one roof.
Production, engineering, quality and export sales in one organisation.
Documentation and packaging prepared per destination market.
Device structure, dose mechanism and assembly process inventions.
Ownership & contract manufacturing
The plant is ours, and it builds under your label
Two questions settle most injection pen sourcing files before price is ever discussed: does the supplier own the plant, and can that plant manufacture for your brand? Short answers first, then the parts we deliberately leave to the contract.
The plant is webosan's own
Moulding, assembly, function testing and packaging all run on our own 10,000 m2 site. We are not a trading company placing orders with a third-party factory, and there is no intermediary between your specification and the people who set the machine. The site you would audit is the site that produces your order.
Contract manufacturing for pharmaceutical companies
We manufacture injection pens for pharma companies under their own brand: device moulding, assembly, function and dose testing, labelling and packaging, plus the batch records that go with each release. Whether the finished pen carries your brand, our platform name, or both is agreed per program.
What belongs in the contract, not the brochure
Tooling ownership, exclusivity and minimum volumes are commercial terms, so we state them in the quotation instead of leaving them to assumption - a disagreement here surfaces at the first audit rather than at signature. Design authority and manufacturer of record are fixed in the quality agreement before the first batch, because your regulatory submission has to name a manufacturer, not an intention.
If your due diligence checklist holds a question this page does not answer, send it over. An unanswered question costs us more than an inconvenient answer.
How the quality system is applied
A quality system is only credible where it is enforced. Three gates stand between incoming material and an export carton.
Incoming inspection
Cartridge shells, springs, damping rings and printed components are sampled against drawing tolerances before release to the line. A failed lot stops the build, it does not get sorted into the batch.
In-process control
Moulding parameters, assembly torque and dial feedback are checked on a documented schedule during the run, not only at the end of it. Dose dial torque is measured as data, not judged by feel.
Pre-shipment verification
Function, dose delivery, needle fit, labelling and packaging are verified on a sampled basis before the carton is closed, with retention samples kept for traceability.
What is in the documentation package
Availability is stated honestly. Anything marked "under NDA" is released once a mutual NDA is signed — asking for it early is normal and expected.
- ISO 13485 quality management documentationUnder NDA
- CE product documentation (injection pens, pen needles, cartridges, kits)Under NDA
- FDA-facing device documentation packageUnder NDA
- China NMPA Class II medical device business filingHeld by webosan
- Product specifications and drawing sheetsOn request
- Third-party test reports for released platformsOn request
- Batch traceability and retention sample recordsUnder NDA
Tooling and intellectual property
Device structure, dose mechanism and assembly process work is protected by more than 50 patents. Tooling developed for a buyer program is a commercial term agreed in the contract, not an assumption — ask for it in writing during quotation.
Patents do not replace a freedom-to-operate review for your market. If your legal team needs an FTO position before launch, raise it at the scoping stage so it runs alongside tooling rather than after it.
50+
Tooling and intellectual property
Quality & compliance
Need the document package before you can shortlist us?
Send your market, device format and expected annual volume. We will reply with the specification set and the documentation list that applies to your program.
Send your target market and device format - we reply with the document list that applies.